Literature DB >> 10743952

The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives.

T H Marsilje1, K L Milkiewicz, D G Hangauer.   

Abstract

A series of hydroxynaphthalene pp60(c-src) non-peptide inhibitors was designed, using the crystal structure of the insulin receptor tyrosine kinase as a qualitative model, to target the peptide substrate binding site. Representative inhibitors were shown to bind non-competitively with respect to ATP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743952     DOI: 10.1016/s0960-894x(00)00039-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases.

Authors:  Abdelsattar M Omar; Maan T Khayat; Farid Ahmed; Yosra A Muhammad; Azizah M Malebari; Sara M Ibrahim; Mohammad I Khan; Dhaval K Shah; Wayne E Childers; Moustafa E El-Araby
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

2.  Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia.

Authors:  Fatih M Uckun; Sanjive Qazi; Ingrid Cely; Kazim Sahin; Anoush Shahidzadeh; Ibrahim Ozercan; Qian Yin; Paul Gaynon; Amanda Termuhlen; Jianjun Cheng; Seang Yiv
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

3.  Src controls castration recurrence of CWR22 prostate cancer xenografts.

Authors:  Bing Su; Bryan Gillard; Lingqiu Gao; Kevin H Eng; Irwin H Gelman
Journal:  Cancer Med       Date:  2013-10-11       Impact factor: 4.452

4.  Beta-hydroxyisovalerylshikonin is a novel and potent inhibitor of protein tyrosine kinases.

Authors:  Sachiko Hashimoto; Ying Xu; Yutaka Masuda; Toshihiro Aiuchi; Shigeo Nakajo; Yoshimasa Uehara; Masabumi Shibuya; Takao Yamori; Kazuyasu Nakaya
Journal:  Jpn J Cancer Res       Date:  2002-08

Review 5.  Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.

Authors:  Meghan E Breen; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2014-12-23       Impact factor: 5.100

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.